Read more
The book presents invaluable insights into the latest advancements, challenges, and research on vaccine adjuvants, which are key to developing more effective and safer vaccines essential for tackling pressing global health challenges. Emerging Pathways of Vaccine Adjuvants: A Nonspecific Stimulant of the Immune System aims to drive progress in vaccine research, paving the way for the development of more potent and safer vaccines to address global health threats. This volume provides a comprehensive overview of the evolving landscape of vaccine adjuvants, encompassing a wide range of topics critical to their design, development, and application. Adjuvants play a crucial role in vaccine formulations by boosting the immunogenicity of antigens, thereby enhancing vaccine efficacy. While antigens can initiate immune responses independently, adjuvants amplify these responses. Extensive research efforts are focused on the formulation of adjuvants to establish accurate, efficient, and safe manufacturing techniques. This book provides a clear explanation of the strict regulatory issues, making it an essential resource for students, businesspeople, and academics across the globe. Readers will find the book:
- Encompasses current adjuvant usage and possible tactics to ensure effective production and delivery of the active constituent;
- Presents challenges and innovations with implications to provide cheaper, more efficient solutions in the industry;
- Prepares students for work in the industry, refining their skills for the production of critical medications.
Audience Researchers and pharmacy students in biomedical engineering and chemical engineering, biotechnology, as well as pharmaceutical and biopharmaceutical industry engineers working in drug discovery, chemical biology, computational chemistry, medicinal chemistry, and bioinformatics.
About the author
Vivek P. Chavda is an assistant professor in the Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Gujarat, India with over eight years of teaching and biologics industry experience. He has more than 200 national and international publications, four edited books, an authored book, and 28 book chapters and is working on three patents. His research interests include the development of biologics processes and formulations, medical device development, nanodiagnostics and non-carrier formulations, long-acting parenteral formulations, and nanovaccines.
Vasso Apostolopoulos, PhD, is a Vice-Chancellor Distinguished Fellow and Director of the Immunology and Translational Research Group at Victoria University, Australia and the Immunology Program Director at the Australian Institute for Musculoskeletal Science, Australia. She is a world-renowned researcher with over 100 awards, 510 research publications, and 22 patents to her credit. Her interests include vaccine and drug development for cancer, chronic, infectious, and autoimmune diseases.
